Shijiazhuang No.4 Pharmaceutical Co., Ltd. Sustainability Profile
Shijiazhuang No.4 Pharmaceutical Co., Ltd., commonly referred to as Shijiazhuang No.4 Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shijiazhuang, China. Established in 1956, the company has evolved significantly, focusing on the research, development, and manufacturing of a diverse range of pharmaceutical products, including APIs (Active Pharmaceutical Ingredients) and finished dosage forms. With a strong presence in both domestic and international markets, Shijiazhuang No.4 Pharma is recognised for its commitment to quality and innovation. The company’s core offerings include a variety of therapeutic agents, particularly in the fields of cardiovascular and anti-infective medications, distinguished by their high efficacy and safety profiles. Over the years, Shijiazhuang No.4 Pharma has achieved notable milestones, solidifying its position as a trusted supplier in the global pharmaceutical landscape.
DitchCarbon Score
How does Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s reported carbon emissions
Shijiazhuang No.4 Pharmaceutical Co., Ltd., headquartered in China, currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of SSY Group Limited, which may influence its climate-related initiatives and reporting. As of now, Shijiazhuang No.4 Pharmaceutical has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). There are no specific climate pledges or initiatives reported that would indicate a proactive stance towards reducing carbon emissions. Given the absence of direct emissions data and reduction targets, it is essential to consider the broader industry context. Pharmaceutical companies are increasingly under pressure to enhance their sustainability practices and reduce their carbon footprints. This includes commitments to transparency in emissions reporting and setting ambitious reduction targets in line with global climate goals. In summary, while Shijiazhuang No.4 Pharmaceutical Co., Ltd. does not currently provide specific emissions data or reduction commitments, its affiliation with SSY Group Limited may play a role in shaping its future climate strategies.
How Carbon Intensive is Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s Location?
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
